Czechia· CZ-0286163
WAINZUA
A eplontersen product containing eplontersen sodium, registered in Czechia by AstraZeneca AB, Södertälje. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- EPLONTERSEN SODIUM
- Manufacturer
- AstraZeneca AB, Södertälje
- Country
- Czechia (CZ)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumWainzua 45 mgAstraZeneca
- IcelandWainzuaAstraZeneca AB*
- NorwayWainzuaAstraZeneca AB
- SwedenWainzua 45 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- IrelandWainzua 45 mg solution for injection in pre-filled penAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Wainzua
- Liechtenstein · Wainzua
- Norway · Wainzua
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1476a812-9263-4e38-9fd9-ddaff7ddd3d8 GET /v1/drugs/1476a812-9263-4e38-9fd9-ddaff7ddd3d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL PEP",
"source": "sukl",
"strength": "45MG",
"pack_size": "1X0,8ML",
"substance": "EPLONTERSEN SODIUM",
"cz_kod_sukl": "0286163",
"product_type": "CH",
"substance_codes": "23471",
"registration_state": "R",
"registration_number": "EU/1/24/1875/001"
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.